Amneal Pharmaceuticals, Inc.
AMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723128
In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 145 | 128 | −17 |
| Shares | 96.8M | 97.5M | +672.9K (+0.7%) |
| Value | $134.7M | $302.0M | +$167.4M (+124.3%) |
New holders (11)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 2,601,379 | $8.06M | 0.35% |
| Brandywine Global Investment Management, LLC | 401,680 | $1.25M | 0.01% |
| Virtu Financial LLC | 35,719 | $111.0K | 0.01% |
| Dynamic Advisor Solutions LLC | 34,200 | $106.0K | 0.01% |
| Winton Group Ltd | 19,068 | $59.1K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 12,150 | $37.7K | 0.00% |
| Group One Trading, L.P. | 880 | $2.73K | 0.00% |
| Lindbrook Capital, LLC | 502 | $1.56K | 0.00% |
| Macroview Investment Management LLC | 1 | $4 | 0.00% |
| Toronto Dominion Bank | 27 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 8 | $0 | 0.00% |
Sold out (28)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.